Citadel Advisors
AGL icon

Citadel Advisors’s Agilon Health AGL Stock Holding History

Citadel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,603
Closed -$802K – 12882
2025
Q4 		$854K Sell
49,603
-104,645
-68% -$2.03M ﹤0.01% 7757
2025
Q3 		$3.97M Buy
154,248
+5,992
+4% +$226K ﹤0.01% 4777
2025
Q2 		$8.52M Sell
148,256
-166,608
-53% -$13.4M ﹤0.01% 3260
2025
Q1 		$34.1M Buy
314,864
+116,899
+59% +$10.2M 0.01% 1477
2024
Q4 		$9.4M Buy
197,965
+113,708
+135% +$6.87M ﹤0.01% 3060
2024
Q3 		$8.28M Buy
84,257
+25,963
+45% +$3.35M ﹤0.01% 3202
2024
Q2 		$9.53M Buy
58,294
+56,711
+3,583% +$8.08M ﹤0.01% 2831
2024
Q1 		$241K Sell
1,583
-30,396
-95% -$5.06M ﹤0.01% 9931
2023
Q4 		$10M Buy
+31,979
New +$11.6M ﹤0.01% 2840
2023
Q3 		– Sell
-10,442
Closed -$4.72M – 14219
2023
Q2 		$4.53M Buy
10,442
+7,968
+322% +$4.48M ﹤0.01% 3799
2023
Q1 		$1.47M Buy
2,474
+2,080
+528% +$1.17M ﹤0.01% 5955
2022
Q4 		$159K Sell
394
-1,208
-75% -$567K ﹤0.01% 10521
2022
Q3 		$938K Buy
+1,602
New +$959K ﹤0.01% 7129
2022
Q2 		– Sell
-4,125
Closed -$2.09M – 12780
2022
Q1 		$2.61M Buy
+4,125
New +$2.13M ﹤0.01% 5487
2021
Q4 		– Sell
-9,579
Closed -$5.83M – 13712
2021
Q3 		$6.28M Sell
9,579
-25,033
-72% -$21.4M ﹤0.01% 3887
2021
Q2 		$35.1M Buy
+34,612
New +$30.3M 0.01% 1449

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors's AGL Position: Q1 2026 in Review

Citadel Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 49,603 shares — an estimated $802K sold.

Citadel Advisors first reported a position in AGL in Q2 2021 and held it in 16 quarters. The position peaked at $35.1M in Q2 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Citadel Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 49,603 Agilon Health shares in Q1 2026, an estimated $802K.
  • Citadel Advisors first reported a position in Agilon Health in Q2 2021 and held it in 16 quarters.
  • Citadel Advisors's Agilon Health position peaked at $35.1M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.